| Scott B. Brown |
Scott B. Brown is currently the Chief Financial Officer at TRACON Pharmaceuticals, Inc. He previously worked as the Associate Director-Finance at Ardea Biosciences, Inc. from 2013 to 2015, Finance Manager at SciClone Pharmaceuticals LLC from 2011 to 2012, Finance Manager at Exelixis, Inc. from 2009 to 2011, and Audit Associate at KPMG LLP in 2008. He holds a graduate degree from San Diego State University and an undergraduate degree from the University of California. |
| David Elliot Lazar |
David Elliot Lazar currently works at Activist Investing LLC, as Chief Executive Officer & Managing Member, Balincan International, Inc., as Chairman, President, CEO, CFO & Secretary from 2021, OpGen, Inc., as Chairman & Chief Executive Officer from 2024, and various other companies. Mr. Lazar also formerly worked at Lvpai Group Ltd., as Chairman, President, CEO, CFO & Secretary from 2020 to 2021, Richland Resources International Group, Inc., as President, CEO, Secretary, Treasurer & Director from 2019 to 2020, Cang Bao Tian Xia International Art Trade Center, Inc., as Chief Executive Officer & Director, and various other companies. |
| James L. Freddo |
James L. Freddo currently works at TRACON Pharmaceuticals, Inc., as Chief Medical Officer from 2020. Dr. Freddo also formerly worked at Pfizer Inc., as Executive Director from 2002 to 2005, Anadys Pharmaceuticals, Inc., as Chief Medical Officer, Director & Senior VP in 2011, InfuSystem Holdings, Inc., as Director from 2008 to 2011, InfuSystem, Inc., as Director in 2011, Wyeth-Ayerst Research, as Senior Director-Oncology & Infectious Diseases from 1996 to 2002, Ignyta, Inc., as Independent Director from 2014 to 2018, Pfizer (St. Louis), as Vice President, Head-Clinical & Development Site from 2005 to 2006, and Aravive Biologics, Inc., as Chief Medical Officer & Head-Clinical Affairs. Dr. Freddo received his undergraduate degree from Stony Brook University and doctorate degree from The University of North Carolina at Charlotte. |
| Charles P. Theuer |
Charles P. Theuer is currently the President, Chief Executive Officer & Director at TRACON Pharmaceuticals, Inc. He is also an Independent Director at 4D Molecular Therapeutics, Inc. and Oncternal Therapeutics, Inc. Previously, he worked as the Director-Clinical Oncology at Pfizer Inc. from 2003 to 2004 and as the Chief Medical Officer & VP-Clinical Development at TargeGen, Inc. from 2004 to 2006. He also held the position of Assistant Professor-Surgical Oncology at the University of California, Irvine. Additionally, he served as Principal at the National Cancer Institute from 1991 to 1993. Dr. Theuer completed his undergraduate degree at the Massachusetts Institute of Technology in 1985. He obtained his doctorate degrees from the University of California, Irvine in 2002 and the University of California, San Francisco in 1989. |
| Martin A. Mattingly |
Martin A. Mattingly is an Independent Director at TRACON Pharmaceuticals, Inc. He previously served as the Chief Executive Officer at Trimeris, Inc. and President & Chief Executive Officer at Ambrx, Inc. He was also an Independent Director at OncoGenex Pharmaceuticals, Inc. and Achieve Life Sciences, Inc. Additionally, he served as the General Manager-HIV Division at Agouron Pharmaceuticals LLC and Vice President-Global Marketing Planning at Pfizer Inc. He was the Chief Operating Officer & Executive Vice President at CancerVax Corp. He holds a doctorate degree from the University of Kentucky. |
| Saundra L. Pelletier |
Saundra L. Pelletier is currently the Chief Executive Officer & Secretary at Evofem Biosciences Operations, Inc. She is also the Chairman, President & Chief Executive Officer at Evofem Biosciences, Inc. and an Independent Director at TRACON Pharmaceuticals, Inc. Additionally, she serves as the Director at The Center For Community Solutions and as a Trustee at Husson University. In her former positions, Ms. Pelletier was the Chief Executive Officer & Director at Evofem, Inc. She also served as the Chief Executive Officer at WomanCare Global International from 2009 to 2016. From 2009 to 2018, she was the Chairman at Catalyst Global. Furthermore, she was a Director at Women First HealthCare, Inc. from 1999 to 2010 and a Director at Willow Foundation. From 2017 to 2019, she served as a Director at Women Deliver. Prior to that, she held the position of Vice President at G.D. Searle LLC from 1992 to 2000. Ms. Pelletier's education includes an undergraduate degree from Husson University and an undergraduate degree from New England School of Communications. |
| Stephen T. Worland |
Stephen T. Worland is the founder of eFFECTOR Therapeutics Operations, Inc. (founded in 2012) where he holds the title of President, Chief Executive Officer & Director. He currently holds the position of President, Chief Executive Officer & Director at eFFECTOR Therapeutics, Inc. (since 2012), Independent Director at TRACON Pharmaceuticals, Inc. (since 2015), Director at Forge Therapeutics, Inc. (since 2017), and Director at Blacksmith Medicines, Inc. (since 2017). Dr. Worland previously held positions as President, Chief Executive Officer & Director at Anadys Pharmaceuticals, Inc. (2007-2011), VP-Antiviral Research & Director-Molecular Biology at Agouron Pharmaceuticals LLC (1988-2001), Independent Non-Executive Director at GenMark Diagnostics, Inc. (2013-2015), and Vice President & Head-Antiviral Research at Pfizer Inc. (2000-2001). He also held a Vice President position at Warner-Lambert Co. Dr. Worland obtained a doctorate degree from the University of California, Berkeley and an undergraduate degree from the University of Michigan. |
| James R. Twiford |
James R. Twiford is the founder of Brookline Partners LLC. He is currently a Director at IPI, Inc., a Director at Integrated Photonics, Inc., an Independent Director at TRACON Pharmaceuticals, Inc., a Director at Camp One Ventures (Fund B) LLC, a Director at Russell County Hospital, a Director at Smith of Georgia LLC, and a Principal at Camp One Ventures LLC. He formerly served as an Independent Director at Tiptree, Inc., a Director at Children's Behavioral Health, Inc., and a Partner at Trammell Crow Co. LLC. Twiford holds graduate degrees from the University of Virginia and the University of Akron, and an undergraduate degree and doctorate from the University of Mississippi. |
| William R. LaRue |
William R. LaRue currently works at TRACON Pharmaceuticals, Inc., as Independent Director from 2014 and Oncternal Therapeutics, Inc., as Independent Director from 2017. Mr. LaRue also formerly worked at Conatus Pharmaceuticals, Inc., as Independent Director from 2017 to 2020, Mallinckrodt Hospital Products, Inc., as CFO, Treasurer, Director & Senior Vice President from 2013 to 2014, Neurelis, Inc., as Director, Applied Proteomics, Inc., as Director, ALASTIN Skincare, Inc., as Director from 2018 to 2021, Oncternal Oncology, Inc., as Director, Safeskin Corp., as Treasurer & Vice President from 1997 to 2000, CancerVax Corp., as Chief Financial Officer & Senior Vice President from 2001 to 2006, GDE Systems, Inc., as Treasurer from 1993 to 1997, eHelp Corp., as Chief Financial Officer & Executive Vice President from 2000 to 2001, Amgen Rockville, Inc., as Chief Financial Officer & Senior Vice President from 2001 to 2006, Amgen Rockville, Inc., as Chief Financial Officer & Senior Vice President from 2001 to 2006, and Cadence, Inc., as Assistant Secretary from 2007 to 2014. Mr. LaRue received his undergraduate degree and Masters Business Admin degree from the University of Southern California. |
| Carol C. Lam |
Carol C. Lam is currently an Independent Director at TRACON Pharmaceuticals, Inc., a Director at Stanford University, and a Director at the National Association of Former United States Attorneys. Previously, she served as a Director at the La Jolla Symphony & Chorus Association and as the Deputy General Counsel & Senior Vice President at QUALCOMM, Inc. Ms. Lam holds a graduate degree from Stanford University and an undergraduate degree from Yale University. |
| Lisa R. Johnson-Pratt |
Lisa R. Johnson-Pratt is the founder of Ananias Ventures, which was founded in 2019. She currently holds multiple positions, including Independent Director at TRACON Pharmaceuticals, Inc., Independent Director at Assembly Biosciences, Inc., Director at Internet Sciences, Inc., Director at Young People in Recovery, and Senior Vice President-Therapeutic Program at Aspen Neuroscience, Inc. Dr. Johnson-Pratt has held former positions such as Business Unit Director at Merck & Co., Inc. from 1996 to 2013, Global Marketing Director at Stiefel Laboratories, Inc. from 2013 to 2015, Head-Global Pharma Commercial Operations at GSK Plc from 2013 to 2019, Senior Vice President-New Product Strategy at Akcea Therapeutics, Inc. in 2020, and Senior Vice President-New Product Planning at Ionis Pharmaceuticals, Inc. from 2020 to 2022. She obtained her undergraduate and doctorate degrees from Howard University. |
